Introduction. Parkinson’s disease (PD) is a progressive neurodegenerative disorder. The disease involves a combination of genetic and environmental factors, although its exact cause remains unclear. Understanding the genetic basis of PD is essential for advancing research and treatment development.
The objective of the study was to explore the genetic diversity of PD within the Algerian population through whole exome sequencing (WES).
Material and methods. WES was conducted on 19 Algerian patients diagnosed with PD, of which eight had a positive family history. Rare variants were defined as having a maximum allele frequency (MAF) between 0.1% and 1%, while novel variants were defined as those with MAF ≤ 0.1% or absent from the reference databases.
Results. Our study revealed a new frameshift variant (c.3692_3693insGC; p.Gln1232fs) in the GIGYF2 gene, a significant finding that has not been previously reported in the Algerian population. Beyond this discovery, our research identified a total of 64 genetic variants distributed across 16 autosomal genes. Many of these genes are already recognized globally for their involvement in Parkinson’s Disease (PD), including PARK7/DJ1, ATP13A2, PINK1, DNAJC6, GBA, UCHL1, SLC6A3, PARK2, LRRK2, NDUFV2, SYN1, and FBXO7. Additionally, HTRA2, EIF4G1, and SNCAIP are considered potential candidate genes or risk factors for PD.
Conclusions. These findings collectively highlight the significant genetic diversity and complexity in the expression of PD among Algerian patients, encompassing various forms of the disease such as early-onset, late-onset, juvenile-onset, and mitochondrial forms.
Keywords: GIGYF2, WES, SNP, Algeria.
Address for correspondence:
Feriel SELLALI
Experimental Biotoxicology on Bioremediation and Phytoremediation Laboratory, Department of Biology, Oran 1 University, Ahmed Ben Bella, Oran, Algeria
Address: B.P. 1524, El M’Naouer -31000 Oran, Algeria
E-mails: sellali.feryal@gmail.com; sellali.feriel@edu.univ-oran1.dz
Phone: 0659603127; Fax: 0021341513048